The performance of companies tied to Sildenafil's past presents a intricate investment scenario . While the initial boom generated substantial returns , generic competition have significantly impacted sales . Investing in connected pharmaceutical businesses now requires a discerning assessment of patent safeguards, evolving medical trends , and the